{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:28:21Z","timestamp":1794716901819,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81974320"],"award-info":[{"award-number":["81974320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81802144"],"award-info":[{"award-number":["81802144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81702133"],"award-info":[{"award-number":["81702133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Excellent Youth Training Program of Shanghai Jiaotong University Affiliated Sixth People\u2019s Hospital","award":["ynyq202102"],"award-info":[{"award-number":["ynyq202102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeting cartilage is a promising strategy for the treatment of osteoarthritis, and various delivery vehicles were developed to assist the therapeutic agents into cartilage. However, the underlying biomechanisms and potential bioactivities remain oversimplified. Inspired by oxidative stress in the pathogenesis of osteoarthritis, we firstly testified the antioxidant capacity of a synthetic small molecule compound, oltipraz (OL), to the chondrocytes treated by IL-1\u03b2. Then a functional reactive oxygen species (ROS) responsive nanocarrier, mesoporous silica nanoparticles (MSN) modified with methoxy polyethylene glycol-thioketal, was constructed. In vitro biomolecular results showed that compared with OL alone, MSN-OL could significantly activate Nrf2\/HO-1 signaling pathway, which exhibited better ROS-scavenging proficiency and greater anti-apoptotic ability to protect mitochondrial membrane potential of chondrocytes. Further bioinformatics analysis revealed that MSN-OL suppressed clusters of genes associated with extracellular matrix organization, cell apoptosis and cellular response to oxidative stress. Animal experiments further confirmed the great cartilage-protecting ability of MSN-OL through upregulating the expression of Nrf2\/HO-1 signaling pathway without obvious toxicity. In summary, this study provided a delivery system through ROS-responsive regulation of the therapeutic agents into chondrocytes of the cartilage, and confirmed the exact biological mechanisms of this innovative strategy.<\/jats:p>","DOI":"10.1186\/s12951-022-01629-w","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:03:12Z","timestamp":1663585392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cartilage targeting therapy with reactive oxygen species-responsive nanocarrier for osteoarthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Zengxin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"issue":"4","key":"1629_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.joca.2014.11.019","volume":"23","author":"V Silverwood","year":"2015","unstructured":"Silverwood V, Blagojevic-Bucknall M, Jinks C, et al. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2015;23(4):507\u201315.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10090","key":"1629_CR2","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","volume":"390","author":"B Costa","year":"2017","unstructured":"Costa B, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390(10090):e21\u201333.","journal-title":"Lancet"},{"key":"1629_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1225","volume":"350","author":"G Machado","year":"2015","unstructured":"Machado G, Maher C, Ferreira P, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350: h1225.","journal-title":"BMJ"},{"issue":"6","key":"1629_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/art.40097","volume":"69","author":"J Qin","year":"2017","unstructured":"Qin J, Barbour K, Murphy L, et al. Lifetime risk of symptomatic hand osteoarthritis: the Johnston County osteoarthritis project. Arthritis Rheumatol. 2017;69(6):1204\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1629_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/antiox10060985","volume":"10","author":"N Tudorachi","year":"2021","unstructured":"Tudorachi N, Totu E, Fifere A, et al. The implication of reactive oxygen species and antioxidants in knee osteoarthritis. Antioxidants (Basel). 2021;10(6):985.","journal-title":"Antioxidants (Basel)"},{"key":"1629_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bone.2016.01.019","volume":"85","author":"M Rahmati","year":"2016","unstructured":"Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone. 2016;85:81\u201390.","journal-title":"Bone"},{"issue":"1","key":"1629_CR7","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1038\/s41467-020-17242-0","volume":"11","author":"M Arra","year":"2020","unstructured":"Arra M, Swarnkar G, Ke K, et al. LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis. Nat Commun. 2020;11(1):3427.","journal-title":"Nat Commun"},{"issue":"7","key":"1629_CR8","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y","volume":"41","author":"S Hashimoto","year":"1998","unstructured":"Hashimoto S, Takahashi K, Amiel D, Coutts R, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum. 1998;41(7):1266\u201374.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1629_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1063-4584(03)00150-X","volume":"11","author":"Y Henrotin","year":"2003","unstructured":"Henrotin Y, Bruckner P, Pujol J. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil. 2003;11(10):747\u201355.","journal-title":"Osteoarthr Cartil"},{"key":"1629_CR10","first-page":"8564681","volume":"2019","author":"X Gao","year":"2019","unstructured":"Gao X, Jiang S, Du Z, Ke A, Liang Q, Li X. KLF2 protects against osteoarthritis by repressing oxidative response through activation of Nrf2\/ARE signaling in vitro and in vivo. Oxid Med Cell Longev. 2019;2019:8564681.","journal-title":"Oxid Med Cell Longev"},{"key":"1629_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117292","volume":"253","author":"J Yao","year":"2020","unstructured":"Yao J, Long H, Zhao J, Zhong G, Li J. Nifedipine inhibits oxidative stress and ameliorates osteoarthritis by activating the nuclear factor erythroid-2-related factor 2 pathway. Life Sci. 2020;253: 117292.","journal-title":"Life Sci"},{"issue":"19","key":"1629_CR12","doi-asserted-by":"publisher","first-page":"19254","DOI":"10.18632\/aging.103757","volume":"12","author":"Z Shao","year":"2020","unstructured":"Shao Z, Pan Z, Lin J, et al. S-allyl cysteine reduces osteoarthritis pathology in the tert-butyl hydroperoxide-treated chondrocytes and the destabilization of the medial meniscus model mice via the Nrf2 signaling pathway. Aging (Albany NY). 2020;12(19):19254\u201372.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1629_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/nyas.13407","volume":"1401","author":"A Marchev","year":"2017","unstructured":"Marchev A, Dimitrova P, Burns A, Kostov R, Dinkova-Kostova A, Georgiev M. Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? Ann NY Acad Sci. 2017;1401(1):114\u201335.","journal-title":"Ann NY Acad Sci"},{"key":"1629_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120111","volume":"291","author":"A Ulasov","year":"2022","unstructured":"Ulasov A, Rosenkranz A, Georgiev G, Sobolev A. Nrf2\/Keap1\/ARE signaling: towards specific regulation. Life Sci. 2022;291: 120111.","journal-title":"Life Sci"},{"issue":"3","key":"1629_CR15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbrc.2020.07.026","volume":"531","author":"Q Sun","year":"2020","unstructured":"Sun Q, Shen X, Ma J, Lou H, Zhang Q. Activation of Nrf2 signaling by oltipraz inhibits death of human macrophages with Mycobacterium tuberculosis infection. Biochem Biophys Res Commun. 2020;531(3):312\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1629_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1517\/17425250903427972","volume":"6","author":"S Choi","year":"2010","unstructured":"Choi S, Kim Y, Lee J, Kim S. Antioxidant and mitochondrial protective effects of oxidized metabolites of oltipraz. Expert Opin Drug Metab Toxicol. 2010;6(2):213\u201324.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"1629_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/apt.13981","volume":"45","author":"W Kim","year":"2017","unstructured":"Kim W, Kim B, Lee J, et al. Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017;45(8):1073\u201383.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1629_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/pharmaceutics13010060","volume":"13","author":"C Salgado","year":"2021","unstructured":"Salgado C, Jordan O, Allemann E. Osteoarthritis in vitro models: applications and implications in development of intra-articular drug delivery systems. Pharmaceutics. 2021;13(1):60.","journal-title":"Pharmaceutics"},{"issue":"11","key":"1629_CR19","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1002\/jps.21346","volume":"97","author":"C Larsen","year":"2008","unstructured":"Larsen C, Ostergaard J, Larsen S, et al. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci. 2008;97(11):4622\u201354.","journal-title":"J Pharm Sci"},{"issue":"8","key":"1629_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.joms.2021.02.034","volume":"79","author":"R Nicot","year":"2021","unstructured":"Nicot R, Barry F, Chijcheapaza-Flores H, et al. A systematic review of rat models with temporomandibular osteoarthritis suitable for the study of emerging prolonged intra-articular drug delivery systems. J Oral Maxillofac Surg. 2021;79(8):1650\u201371.","journal-title":"J Oral Maxillofac Surg"},{"key":"1629_CR21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jconrel.2020.08.041","volume":"328","author":"F Colella","year":"2020","unstructured":"Colella F, Garcia J, Sorbona M, et al. Drug delivery in intervertebral disc degeneration and osteoarthritis: selecting the optimal platform for the delivery of disease-modifying agents. J Control Release. 2020;328:985\u201399.","journal-title":"J Control Release"},{"key":"1629_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2020.10.012","volume":"160","author":"M Tryfonidou","year":"2020","unstructured":"Tryfonidou M, Vries G, Hennink W, Creemers L. \u201cOld Drugs, New Tricks\u201d - Local controlled drug release systems for treatment of degenerative joint disease. Adv Drug Deliv Rev. 2020;160:170\u201385.","journal-title":"Adv Drug Deliv Rev"},{"issue":"18","key":"1629_CR23","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/smll.200901789","volume":"6","author":"J Vivero-Escoto","year":"2010","unstructured":"Vivero-Escoto J, Slowing I, Trewyn B, Lin V. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010;6(18):1952\u201367.","journal-title":"Small"},{"issue":"4","key":"1629_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/jbm.a.37074","volume":"109","author":"L Castro","year":"2021","unstructured":"Castro L, Garcia A, Guldberg R. Biomaterial strategies for improved intra-articular drug delivery. J Biomed Mater Res A. 2021;109(4):426\u201336.","journal-title":"J Biomed Mater Res A"},{"key":"1629_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.actbio.2019.03.010","volume":"93","author":"S Brown","year":"2019","unstructured":"Brown S, Kumar S, Sharma B. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater. 2019;93:239\u201357.","journal-title":"Acta Biomater"},{"issue":"4","key":"1629_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11926-020-0884-z","volume":"22","author":"R Mohammadinejad","year":"2020","unstructured":"Mohammadinejad R, Ashrafizadeh M, Pardakhty A, et al. Nanotechnological strategies for osteoarthritis diagnosis, monitoring, clinical management, and regenerative medicine: recent advances and future opportunities. Curr Rheumatol Rep. 2020;22(4):12.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"1629_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/cm0011559","volume":"13","author":"M Vallet-Regi","year":"2001","unstructured":"Vallet-Regi M, R\u00e1mila A, Real R, P\u00e9rez-Pariente J. Materials, a new property of MCM-41: drug delivery system. Chem Mater. 2001;13(2):308\u201311.","journal-title":"Chem Mater"},{"issue":"12","key":"1629_CR28","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/adma.201104763","volume":"24","author":"F Tang","year":"2012","unstructured":"Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504\u201334.","journal-title":"Adv Mater"},{"issue":"4","key":"1629_CR29","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/nano5041906","volume":"5","author":"M Mart\u00ednez-Carmona","year":"2015","unstructured":"Mart\u00ednez-Carmona M, Colilla M, Vallet-Reg\u00ed M. Smart mesoporous nanomaterials for antitumor therapy. Nanomaterials (Basel). 2015;5(4):1906\u201337.","journal-title":"Nanomaterials (Basel)"},{"issue":"2","key":"1629_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17425247.2016.1211637","volume":"14","author":"R Castillo","year":"2017","unstructured":"Castillo R, Colilla M, Vallet-Reg\u00ed M. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Expert Opin Drug Deliv. 2017;14(2):229\u201343.","journal-title":"Expert Opin Drug Deliv"},{"key":"1629_CR31","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.2147\/IJN.S198848","volume":"14","author":"N Iturrioz-Rodriguez","year":"2019","unstructured":"Iturrioz-Rodriguez N, Correa-Duarte M, Fanarraga M. Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles. Int J Nanomedicine. 2019;14:3389\u2013401.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1629_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/molecules23010047","volume":"23","author":"M Vallet-Regi","year":"2017","unstructured":"Vallet-Regi M, Colilla M, Izquierdo-Barba I, Manzano M. Mesoporous silica nanoparticles for drug delivery: current insights. Molecules. 2017;23(1):47.","journal-title":"Molecules"},{"issue":"2","key":"1629_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313\u201327.","journal-title":"Nanomedicine"},{"issue":"6","key":"1629_CR34","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1184","volume":"11","author":"L Chen","year":"2019","unstructured":"Chen L, Zhou X, He C. Mesoporous silica nanoparticles for tissue-engineering applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11(6): e1573.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"11","key":"1629_CR35","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.1021\/acsnano.5b04306","volume":"9","author":"Z Li","year":"2015","unstructured":"Li Z, Clemens D, Lee B, Dillon B, Horwitz M, Zink J. Mesoporous silica nanoparticles with pH-sensitive nanovalves for delivery of moxifloxacin provide improved treatment of lethal pneumonic tularemia. ACS Nano. 2015;9(11):10778\u201389.","journal-title":"ACS Nano"},{"issue":"10","key":"1629_CR36","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1039\/c3dt53071j","volume":"43","author":"J Zhang","year":"2014","unstructured":"Zhang J, Niemela M, Westermarck J, Rosenholm J. Mesoporous silica nanoparticles with redox-responsive surface linkers for charge-reversible loading and release of short oligonucleotides. Dalton Trans. 2014;43(10):4115\u201326.","journal-title":"Dalton Trans"},{"key":"1629_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.msec.2019.01.129","volume":"99","author":"T Thi","year":"2019","unstructured":"Thi T, Cao V, Nguyen T, Hoang D, Ngo V, Nguyen D. Functionalized mesoporous silica nanoparticles and biomedical applications. Mater Sci Eng C Mater Biol Appl. 2019;99:631\u201356.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"11","key":"1629_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmat2859","volume":"9","author":"D Wilson","year":"2010","unstructured":"Wilson D, Dalmasso G, Wang L, Sitaraman S, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-\u03b1-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater. 2010;9(11):923\u20138.","journal-title":"Nat Mater"},{"issue":"3","key":"1629_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/0885328219845081","volume":"34","author":"N Zheng","year":"2019","unstructured":"Zheng N, Xie D, Zhang Z, et al. Thioketal-crosslinked: ROS-degradable polycations for enhanced in vitro and in vivo gene delivery with self-diminished cytotoxicity. J Biomater Appl. 2019;34(3):326\u201338.","journal-title":"J Biomater Appl"},{"key":"1629_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111223","volume":"194","author":"Q Pan","year":"2020","unstructured":"Pan Q, Deng X, Gao W, Chang J, Pu Y, He B. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy. Colloids Surf B Biointerfaces. 2020;194: 111223.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"1629_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1021\/acsnano.0c01083","volume":"15","author":"Z Liu","year":"2021","unstructured":"Liu Z, Simchick G, Qiao J, et al. Reactive oxygen species-triggered dissociation of a polyrotaxane-based nanochelator for enhanced clearance of systemic and hepatic iron. ACS Nano. 2021;15(1):419\u201333.","journal-title":"ACS Nano"},{"issue":"6","key":"1629_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"O Jeon","year":"2017","unstructured":"Jeon O, Kim C, Laberge R, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017;23(6):775\u201381.","journal-title":"Nat Med"},{"key":"1629_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14:13\u201329.","journal-title":"Osteoarthr Cartil"},{"key":"1629_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/jor.1100100107","volume":"10","author":"JA van der Sluijs","year":"1992","unstructured":"van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res. 1992;10:58\u201361.","journal-title":"J Orthop Res"},{"key":"1629_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cellsig.2018.10.005","volume":"53","author":"Z Jenei-Lanzl","year":"2019","unstructured":"Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1\u03b2 signaling in osteoarthritis\u2014chondrocytes in focus. Cell Signal. 2019;53:212\u201323.","journal-title":"Cell Signal"},{"issue":"2","key":"1629_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1022945107762","volume":"8","author":"J Ly","year":"2003","unstructured":"Ly J, Grubb D, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 2003;8(2):115\u201328.","journal-title":"Apoptosis"},{"issue":"6","key":"1629_CR47","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nm.3143","volume":"19","author":"G Zhen","year":"2013","unstructured":"Zhen G, Wen C, Jia X, et al. Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013;19(6):704\u201312.","journal-title":"Nat Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01629-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01629-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01629-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T05:03:09Z","timestamp":1701061389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01629-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01629-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}